According to a market research analysis by The Insight Partners titled "Viral Vector & Plasmid DNA Manufacturing Market to 2027 - Global Analysis and Forecast by Product, and Application," the market for this product is anticipated to grow from US$ 459.4 million in 2019 to US$ 2,247.7 million by 2027. From 2020 to 2027, the market is anticipated to expand at a CAGR of 22.1%. The study identifies trends in the global market for the production of viral vectors and plasmid DNA as well as key drivers and inhibitors.

The market for the production of viral vectors and plasmid DNA is anticipated to expand as a result of factors including rising interest in gene therapy and an increase in the prevalence of infectious diseases and genetic abnormalities globally. Additionally, the market in the upcoming years is probably going to benefit from the expansion of the worldwide healthcare sector.

Get Sample Copy of Report PDF: https://www.theinsightpartners.com/sample/TIPRE00003074/

Viral vectors and non-viral vectors are the two product categories into which the global viral vector & plasmid DNA production market is divided. Due to the increasing preference for viral vectors in gene transfer, which is demonstrated by the rise in clinical studies for viral vector-mediated gene therapy and the number of initiatives launched by market players, the viral vectors segment held the greatest share of the market in 2019. Viral vectors are a popular option for gene transfer due to their efficient gene delivery, high transfection efficiency, and steady gene expression. For instance, 372 clinical trials involving the generation of vector-mediated gene therapy were registered in 2019.

Among the top businesses in the viral vector & plasmid DNA manufacturing industry are Brammer Bio, Sanofi, Cardinal Health Inc., FUJIFILM Diosynth Biotechnologies, Cobra Biologics, FinVector, Kaneka Eurogentec S.A., MassBiologics, Spark Therapeutics, and Uniqure.

The report segments global viral vector & plasmid DNA manufacturing market as follows:

By Product

• Viral Vectors
• Non-Viral Vectors

By Application

• Cancer
• Inherited Disorders
• Viral Infections
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy
• Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Middle East & Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
• South & Central America (SCAM)
  • Brazil
  • Argentina

Browse More Related Reports by the insight partners:

Viral Vector & Plasmid DNA Manufacturing Market

https://www.theinsightpartners.com/reports/viral-vector-and-plasmid-dna-manufacturing-market

Narcolepsy Market

https://www.theinsightpartners.com/reports/narcolepsy-market

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876